Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BRAINSTORM CELL THERAPEUTICS INC.

(BCLI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
3.24(c) 3.14(c) 3.53(c) 3.48(c) 3.53 Last
96 509 124 259 915 175 185 834 124 481 Volume
-1.22% -3.09% +12.42% -1.42% +1.44% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -31,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -4,05x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -39,4 M - -
Net Debt 2022 - - -
P/E ratio 2022 -3,41x
Yield 2022 -
Capitalization 126 M 126 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 39
Free-Float 82,6%
More Financials
Company
Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is focused on development of cellular therapies for the treatment of neurodegenerative diseases, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease), Progressive Multiple Sclerosis (PMS), Alzheimer's disease (AD) and other neurodegenerative diseases. The Company offers its services through NurOwn platform. Its... 
More about the company
All news about BRAINSTORM CELL THERAPEUTICS INC.
09/01CIDARA THERAPEUTICS : Appoints Preetam Shah Chief Financial Officer
MT
08/25BRAINSTORM CELL THERAPEUTICS : Chief Financial Officer Preetam Shah Plans to Res..
MT
08/25BRAINSTORM CELL THERAPEUTICS INC. : Change in Directors or Principal Officers (f..
AQ
08/25Brainstorm Cell Therapeutics Inc. Announces Executive Changes
CI
08/25Brainstorm Cell Therapeutics Inc. Announces Executive Changes
CI
08/13BRAINSTORM CELL THERAPEUTICS INC. : Termination of a Material Definitive Agreeme..
AQ
08/05BRAINSTORM CELL THERAPEUTICS : Management's Discussion and Analysis of Financial..
AQ
08/05BRAINSTORM CELL THERAPEUTICS INC. : Results of Operations and Financial Conditio..
AQ
08/05Brainstorm Cell Therapeutics Inc. Reports Earnings Results for the Second Qua..
CI
08/05Earnings Flash (GHDN) BRAINSTORM CELL THERAPEUTICS Reports Q2 Loss $-0.17
MT
08/05BRAINSTORM CELL THERAPEUTICS : Announces Second Quarter 2021 Financial Results a..
PR
07/28BRAINSTORM CELL THERAPEUTICS : Increases Commercial Manufacturing Capacity Grant..
AQ
06/25BRAINSTORM CELL THERAPEUTICS INC.(NA : BCLI) dropped from Russell Small Cap Comp..
CI
06/25BRAINSTORM CELL THERAPEUTICS INC.(NA : BCLI) dropped from Russell 2000 Index
CI
06/25BRAINSTORM CELL THERAPEUTICS INC.(NA : BCLI) dropped from Russell Small Cap Comp..
CI
More news
News in other languages on BRAINSTORM CELL THERAPEUTICS INC.
09/01Cidara Therapeutics nomme Preetam Shah directeur financier
2020Catalent et BrainStorm Cell Therapeutics annoncent un partenariat pour la con..
More news
Analyst Recommendations on BRAINSTORM CELL THERAPEUTICS INC.
More recommendations
Chart BRAINSTORM CELL THERAPEUTICS INC.
Duration : Period :
Brainstorm Cell Therapeutics Inc. Technical Analysis Chart | BCLI | US10501E2019 | MarketScreener
Technical analysis trends BRAINSTORM CELL THERAPEUTICS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 3,48 $
Average target price 11,50 $
Spread / Average Target 230%
EPS Revisions
Managers and Directors
Chaim Lebovits Chief Executive Officer
Ralph Z. Kern President & Chief Medical Officer
Alla Patlis Chief Financial Officer & Controller
Jacob Aharon Frenkel Chairman
Yael Gothelf Vice President-Scientific & Regulatory Affairs
Sector and Competitors
1st jan.Capi. (M$)
BRAINSTORM CELL THERAPEUTICS INC.-21.99%126
MODERNA, INC.321.80%177 867
LONZA GROUP AG36.36%62 278
IQVIA HOLDINGS INC.43.91%49 407
CELLTRION, INC.-23.26%31 021
SEAGEN INC.-12.32%27 940